Overcoming self-destruction in the pancreas

Current Opinion in Biotechnology

Volumn 20, Issue 5, 2009, Pages 511-515

  Nichols, Jennifer ^a,b   Cooke, Anne ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b University of Cambridge   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; BETA CELL; DRUG DISCOVERY; EMBRYONIC STEM CELLS; GLUCOSE HOMEOSTASIS; IMMUNE SUPPRESSION; ISLET TRANSPLANTATION; MOUSE MODELS; PANCREATIC BETA CELLS; PANCREATIC TISSUE; STEM CELL; TYPE 1 DIABETES;

CELLS; DRUG THERAPY; GLUCOSE; INSULIN; MEDICAL PROBLEMS;

DISEASE CONTROL;

CD3 ANTIBODY; EPIDERMAL GROWTH FACTOR; GASTRIN; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

BIOSYNTHESIS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL REGENERATION; GENETIC ASSOCIATION; GENETIC MANIPULATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEM CELL;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; PANCREATIC DISEASES;

EID: 70449623531     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2009.09.009     Document Type: Review

References (44)

1. Kikutani H., and Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51 (1992) 285-322
2. Hutchings P., Rosen H., O'Reilly L., Simpson E., Gordon S., and Cooke A. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348 (1990) 639-642
3. Miller B.J., Appel M.C., O'Neil J.J., and Wicker L.S. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140 (1988) 52-58
4. Nagata M., Santamaria P., Kawamura T., Utsugi T., and Yoon J.W. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol 152 (1994) 2042-2050
5. Concannon P., Rich S.S., and Nepom G.T. Genetics of type 1A diabetes. N Engl J Med 360 (2009) 1646-1654
6. Wicker L.S., Todd J.A., and Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13 (1995) 179-200
7. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., Julier C., Morahan G., Nerup J., Nierras C., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009)
8. Dor Y., Brown J., Martinez O.I., and Melton D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429 (2004) 41-46
9. Bonner-Weir S., Inada A., Yatoh S., Li W.C., Aye T., Toschi E., and Sharma A. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans 36 (2008) 353-356
10. O'Reilly L.A., Gu D., Sarvetnick N., Edlund H., Phillips J.M., Fulford T., and Cooke A. alpha-Cell neogenesis in an animal model of IDDM. Diabetes 46 (1997) 599-606
11. Xu X., D'Hoker J., Stange G., Bonne S., De Leu N., Xiao X., Van De Casteele M., Mellitzer G., Ling Z., Pipeleers D., et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132 (2008) 197-207
12. Meier J.J., Bhushan A., Butler A.E., Rizza R.A., and Butler P.C. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?. Diabetologia 48 (2005) 2221-2228
13. Jonsson J., Ahlgren U., Edlund T., and Edlund H. IPF1, a homeodomain protein with a dual function in pancreas development. Int J Dev Biol 39 (1995) 789-798
14. Jonsson J., Carlsson L., Edlund T., and Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371 (1994) 606-609
15. Chatenoud L., Thervet E., Primo J., and Bach J.F. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A 91 (1994) 123-127
16. Hutchings P., O'Reilly L., Parish N.M., Waldmann H., and Cooke A. The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to beta cells in NOD mice. Eur J Immunol 22 (1992) 1913-1918
17. Herold K.C., Gitelman S.E., Masharani U., Hagopian W., Bisikirska B., Donaldson D., Rother K., Diamond B., Harlan D.M., and Bluestone J.A. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54 (2005) 1763-1769
18. Keymeulen B., Vandemeulebroucke E., Ziegler A.G., Mathieu C., Kaufman L., Hale G., Gorus F., Goldman M., Walter M., Candon S., et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352 (2005) 2598-2608
19. Phillips J.M., O'Reilly L., Bland C., Foulis A.K., and Cooke A. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes 56 (2007) 634-640
20. Nir T., Melton D.A., and Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 117 (2007) 2553-2561
21. Phillips J.M., Harach S.Z., Parish N.M., Fehervari Z., Haskins K., and Cooke A. Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells. J Immunol 165 (2000) 1949-1955
22. Belghith M., Bluestone J.A., Barriot S., Megret J., Bach J.F., and Chatenoud L. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9 (2003) 1202-1208
23. Tulachan S.S., Tei E., Hembree M., Crisera C., Prasadan K., Koizumi M., Shah S., Guo P., Bottinger E., and Gittes G.K. TGF-beta isoform signaling regulates secondary transition and mesenchymal-induced endocrine development in the embryonic mouse pancreas. Dev Biol 305 (2007) 508-521
24. Setzu A., Lathia J.D., Zhao C., Wells K., Rao M.S., Ffrench-Constant C., and Franklin R.J. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54 (2006) 297-303
25. Suarez-Pinzon W.L., Yan Y., Power R., Brand S.J., and Rabinovitch A. Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 54 (2005) 2596-2601
26. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., Meyer E.M., Morel L., Petersen B.E., and Scott E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
27. Vassilopoulos G., Wang P.R., and Russell D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 422 (2003) 901-904
28. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., Lagasse E., Finegold M., Olson S., and Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422 (2003) 897-901
29. Chopp M., Zhang X.H., Li Y., Wang L., Chen J., Lu D., Lu M., and Rosenblum M. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11 (2000) 3001-3005
30. Hess D., Li L., Martin M., Sakano S., Hill D., Strutt B., Thyssen S., Gray D.A., and Bhatia M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21 (2003) 763-770
31. Ianus A., Holz G.G., Theise N.D., and Hussain M.A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111 (2003) 843-850
32. Lechner A., Yang Y.G., Blacken R.A., Wang L., Nolan A.L., and Habener J.F. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 53 (2004) 616-623
33. Mathews V., Hanson P.T., Ford E., Fujita J., Polonsky K.S., and Graubert T.A. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 53 (2004) 91-98
34. Zhang C., Todorov I., Lin C.L., Atkinson M., Kandeel F., Forman S., and Zeng D. Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice. Proc Natl Acad Sci U S A 104 (2007) 2337-2342
35. Fujikawa T., Oh S.H., Pi L., Hatch H.M., Shupe T., and Petersen B.E. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 166 (2005) 1781-1791
36. Lumelsky N., Blondel O., Laeng P., Velasco I., Ravin R., and McKay. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292 (2001) 1389-1394
37. Borowiak M., Maehr R., Chen S., Chen A.E., Tang W., Fox J.L., Schreiber S.L., and Melton D.A. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 4 (2009) 348-358
38. Chen S., Borowiak M., Fox J.L., Maehr R., Osafune K., Davidow L., Lam K., Peng L.F., Schreiber S.L., Rubin L.L., and Melton D. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol 5 (2009) 258-265
39. Hanna J., Markoulaki S., Mitalipova M., Cheng A.W., Cassady J.P., Staerk J., Carey B.W., Lengner C.J., Foreman R., Love J., et al. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4 (2009) 513-524
40. Nichols J., Jones K., Phillips J.M., Newland S.A., Roode M., Mansfield W., Smith A., and Cooke A. Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat Med 15 (2009) 814-818
41. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
42. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
43. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., Trauger S., Bien G., Yao S., Zhu Y., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4 (2009) 381-384
44. Huangfu D., Maehr R., Guo W., Eijkelenboom A., Snitow M., Chen A.E., and Melton D.A. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26 (2008) 795-797